• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Ortho Clinical Diagnostics Plc (NQ: OCDX )

    N/A UNCHANGED
    Last Price Updated: 4:00 PM EDT, May 26, 2022 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Headline News about Ortho Clinical Diagnostics Plc

    Benzinga's Top Ratings Upgrades, Downgrades For February 17, 2022
    Upgrades HSBC upgraded the previous rating for Equinor ASA (NYSE:EQNR) from Hold to Buy. For the fourth quarter, Equinor had an EPS of $1.35, compared to year-ago quarter EPS of $... 
    Via Benzinga
    Ortho Clinical Diagnostics' Q4 EPS Beat Estimates
    Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX)  
    Via Benzinga
    Ortho Clinical Diagnostic: Q4 Earnings Insights
    Ortho Clinical Diagnostic (NASDAQ:OCDX) reported its Q4 earnings results on Wednesday, February 16, 2022 at 04:30 PM. Here's what investors need to know about the announcement. 
    Via Benzinga
    Earnings Scheduled For February 16, 2022
    Companies Reporting Before The Bell • Wix.com (NASDAQ:WIX) is projected to report quarterly loss at $0.38 per share on revenue of $331.16 million. 
    Via Benzinga
    Ortho Clinical Diagnostic Earnings Preview
    Ortho Clinical Diagnostic (NASDAQ:OCDX) is set to give its latest quarterly earnings report on Wednesday, 2022-02-16. Here's what investors need to know before the announcement. Analysts estimate that... 
    Via Benzinga
    12 Health Care Stocks Moving In Friday's After-Market Session
    Gainers Quidel (NASDAQ:QDEL) shares incre... 
    Via Benzinga
    12 Health Care Stocks Moving In Thursday's After-Market Session
    Gainers Cidara Therapeutics (NASDAQ:CDTX)... 
    Via Benzinga
    10 Biggest Price Target Changes For Monday
    Morgan Stanley cut Foot Locker, Inc. (NYSE:FL) price... 
    Via Benzinga
    CROX Stock: The $2.5B HEYDUDE Deal That Has Crocs Investors Crying Today
    Crocs (CROX) stock isn't doing so hot on Thursday after the footwear company announced a massive $2.5 billion deal for HEYDUDE. 
    Via InvestorPlace
    OCDX Stock Alert: 9 Things to Know About the Quidel Deal Sending Ortho Clinical Higher
    Quidel will acquire OCDX stock for $24.68 per share and newly issued stock. The transaction will be worth a total of $6 billion. 
    Via InvestorPlace
    Tesla Leads Automobile Stocks to be Among Wednesday's Top Performers
    Stock index futures point higher as investors look to add to two days of gains. Thursday is the last trading day of the week because markets are closed on Friday in observance of... 
    Via Benzinga
    Quidel To Buy Ortho Clinical Diagnostics For $24.68/Share: Highlights
    Quidel Corp (NASDAQ: QDEL) has agreed to acquire Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) for $24.68 per share in cash and newly issued shares in... 
    Via Benzinga
    Free COVID Tests: What Stocks Will Benefit?
    The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
    Via Talk Markets
    Ortho Clinical Diagnostics Holdings plc (OCDX) Q3 2021 Earnings Call Transcript
    OCDX earnings call for the period ending September 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
    Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics... 
    Via Benzinga
    Topics Retirement
    Exposures Pension
    Ortho Clinical Diagnostics Holdings plc (OCDX) Q2 2021 Earnings Call Transcript
    OCDX earnings call for the period ending June 30, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    Ortho Clinical Diagnostics' COVID-19 Antibody Test Gets FDA Emergency Use Approval
    The FDA has granted Emergency Use Authorization (EUA) to Ortho Clinical Diagnostics' (NASDAQ: OCDX) VITROS Anti-SARS-CoV-2 IgG Quantitative Test. The... 
    Via Benzinga
    Exposures COVID-19 Product Safety
    The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
    Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc... 
    Via Benzinga
    The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (... 
    Via Benzinga
    Ortho Clinical Diagnostics Holdings plc (OCDX) Q1 2021 Earnings Call Transcript
    OCDX earnings call for the period ending March 31, 2021. 
    Via The Motley Fool
    Topics Earnings
    Exposures Financial
    48 Biggest Movers From Yesterday
    Gainers Rocket Lab USA, Inc. (NASDAQ: RKLB) jumped 37.3% to settle at $20.72. Rocket Lab reported 1H sales of $29.5 million and announced it has been awarded a contract to deploy... 
    Via Benzinga
    The Daily Biotech Pulse: AstraZeneca, Biogen Face Clinical Trial Disappointments, Novavax Studies Coronavirus-Flu Combo Vaccine, Decision Day For Takeda
    Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 14) Alkermes plc (NASDAQ: ALKS... 
    Via Benzinga
    The Daily Biotech Pulse: Quidel Slides On Negative Pre-Announcement, Roche Gets Positive EMA Committee Recommendation, 3 IPOs
    Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 22) AtriCure, Inc. (NASDAQ:... 
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.